Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah C Glover

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Archivum Immunologiae Et Therapiae Experimentalis|August 30, 2018
Innate Lymphoid Cells in Inflammatory Bowel DiseaseJian Li, Sarah C Glover
Inflammation and Cell Signaling|March 14, 2017
Aryl hydrocarbon receptor signaling involves in the human intestinal ILC3/ILC1 conversion in the inflamed terminal ileum of Crohn's disease patientsJian Li, Andria Doty, Sarah C Glover
The American Journal of Gastroenterology|October 4, 2022
Getting by With Less: How to do More With Less Staff After COVID-19?Vonda Reeves, David Schaefer, Sarah C Glover
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 13, 2021
Hereditary alpha-tryptasemia despite normal tryptase-encoding gene copy number owing to copy number loss in transSarah C Glover, Alexander Carlyle, Jonathan J Lyons
Expert Review of Clinical Immunology|April 3, 2014
Febrile pleuropericarditis, a potentially life-threatening adverse event of balsalazide--case report and literature review of the side effects of 5-aminosalicylatesRoxana M Coman, Sarah C Glover, Altin Gjymishka
Cellular Immunology|May 25, 2016
The differential frequency of Lineage(-)CRTH2(-)CD45(+)NKp44(-)CD117(-)CD127(+)ILC subset in the inflamed terminal ileum of patients with Crohn's diseaseJian Li, Andria L Doty, Atif Iqbal, et al.
Immunotherapy|November 29, 2013
Influence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and Type 1 diabetesAltin Gjymishka, Roxana M Coman, Todd M Brusko, et al.
International Journal of Cell Biology|June 13, 2012
Treatment with Y-27632, a ROCK Inhibitor, Increases the Proinvasive Nature of SW620 Cells on 3D Collagen Type 1 MatrixRamana Vishnubhotla, Shruthi Bharadwaj, Shan Sun, et al.
Digestive Diseases and Sciences|February 28, 2025
Delays in Utilizing Biological Therapy Is a Global Reality and May Lead to Negative Outcomes in Patients with Inflammatory Bowel DiseaseAnna H Owings, Sarah C Glover, Adam S Cheifetz, et al.
In Vivo (Athens, Greece)|December 28, 2018
Small Bowel Pyogenic Granuloma With Cytomegalovirus Infection in a Patient With Crohn's Disease (Report of a Case and Review of the Literature)Dongwei Zhang, Sarah C Glover, Weidong Liu, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Archivum Immunologiae Et Therapiae Experimentalis|August 30, 2018
Innate Lymphoid Cells in Inflammatory Bowel DiseaseJian Li, Sarah C Glover
Inflammation and Cell Signaling|March 14, 2017
Aryl hydrocarbon receptor signaling involves in the human intestinal ILC3/ILC1 conversion in the inflamed terminal ileum of Crohn's disease patientsJian Li, Andria Doty, Sarah C Glover
The American Journal of Gastroenterology|October 4, 2022
Getting by With Less: How to do More With Less Staff After COVID-19?Vonda Reeves, David Schaefer, Sarah C Glover
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 13, 2021
Hereditary alpha-tryptasemia despite normal tryptase-encoding gene copy number owing to copy number loss in transSarah C Glover, Alexander Carlyle, Jonathan J Lyons
Expert Review of Clinical Immunology|April 3, 2014
Febrile pleuropericarditis, a potentially life-threatening adverse event of balsalazide--case report and literature review of the side effects of 5-aminosalicylatesRoxana M Coman, Sarah C Glover, Altin Gjymishka
Cellular Immunology|May 25, 2016
The differential frequency of Lineage(-)CRTH2(-)CD45(+)NKp44(-)CD117(-)CD127(+)ILC subset in the inflamed terminal ileum of patients with Crohn's diseaseJian Li, Andria L Doty, Atif Iqbal, et al.
Immunotherapy|November 29, 2013
Influence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and Type 1 diabetesAltin Gjymishka, Roxana M Coman, Todd M Brusko, et al.
International Journal of Cell Biology|June 13, 2012
Treatment with Y-27632, a ROCK Inhibitor, Increases the Proinvasive Nature of SW620 Cells on 3D Collagen Type 1 MatrixRamana Vishnubhotla, Shruthi Bharadwaj, Shan Sun, et al.
Digestive Diseases and Sciences|February 28, 2025
Delays in Utilizing Biological Therapy Is a Global Reality and May Lead to Negative Outcomes in Patients with Inflammatory Bowel DiseaseAnna H Owings, Sarah C Glover, Adam S Cheifetz, et al.
In Vivo (Athens, Greece)|December 28, 2018
Small Bowel Pyogenic Granuloma With Cytomegalovirus Infection in a Patient With Crohn's Disease (Report of a Case and Review of the Literature)Dongwei Zhang, Sarah C Glover, Weidong Liu, et al.
Pageof 7